Prof. Wilson holds the Chair in Drug Metabolism and Molecular Toxicology.
Ian Wilson trained as a biochemist at the University of Manchester Institute of Science and Technology, going on to a PhD at Keele University on insect moulting hormones. After this he worked in the Pharmaceutical industry, most recently as a Senior Principal Scientist in the Dept of Drug Metabolism and Pharmacokinetics at the AstraZeneca Research site at Alderley Park in Cheshire (UK), joining Imperial College in 2012. He is the author, or co-author, of some 480 papers or reviews, and has received a number of awards in separation and analytical science from the Royal Society of Chemistry, including the Gold Medal of the Analytical Division (2005) and most recently the Knox Medal of the RSC Separation Science Group (2012). He received the Jubilee Medal of the Chromatographic Society in 1994 and gave the inaugural Desty Memorial lecture for Innovation in Separation Science in1996. His research is directed towards the development of hyphenated techniques in chromatography and their application to problems in drug metabolism, toxicology and metabonomics
et al., 2017, Application of H-1 NMR spectroscopy to the metabolic phenotyping of rodent brain extracts: A metabonomic study of gut microbial influence on host brain metabolism, Journal of Pharmaceutical and Biomedical Analysis, Vol:143, ISSN:0731-7085, Pages:141-146
et al., 2017, Ion mobility spectrometry combined with ultra performance liquid chromatography/mass spectrometry for metabolic phenotyping of urine: Effects of column length, gradient duration and ion mobility spectrometry on metabolite detection, Analytica Chimica Acta, Vol:982, ISSN:0003-2670, Pages:1-8
et al., 2017, Hyphenated MS-based targeted approaches in metabolomics., Analyst, Vol:142, Pages:3079-3100
et al., 2017, Stability in metabolic phenotypes and inferred metagenome profiles before the onset of colitis-induced inflammation, Scientific Reports, Vol:7, ISSN:2045-2322
et al., 2017, Acute liver effects, disposition and metabolic fate of [(14)C]-fenclozic acid following oral administration to normal and bile-cannulated male C57BL/6J mice., Arch Toxicol, Vol:91, Pages:2643-2653